Cargando…
Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study
Denosumab increases bone mineral density (BMD) in patients not receiving hemodialysis therapy. However, limited data are available in the literature concerning the use of denosumab in hemodialysis patients. We treated male hemodialysis patients with low radius BMD with denosumab therapy for 1 year a...
Autores principales: | Takami, Hiroya, Washio, Kazunori, Gotoh, Hiromichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585574/ https://www.ncbi.nlm.nih.gov/pubmed/28912972 http://dx.doi.org/10.1155/2017/6218129 |
Ejemplares similares
-
Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis
por: Wang, Yilin, et al.
Publicado: (2023) -
Value of quantitative ultrasound and bioelectrical impedance analysis in detecting low bone mineral density in hemodialysis
por: Xiang, Ting, et al.
Publicado: (2021) -
Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
por: Makras, Polyzois, et al.
Publicado: (2021) -
The Relationship between Cortisol and Bone Mineral Density in Competitive Male Cyclists
por: Mathis, Shannon L., et al.
Publicado: (2013) -
Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone
por: Wang, Yan-Jiao, et al.
Publicado: (2013)